Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Anhui Medical UniversityActive in the last 2 years

Zhongxu Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-6228-5843; OpenAlex author ID A5100906173. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. Thermoresponsive NDP hydrogel embedded with MnO2 nanoparticles for postoperative antirecurrence therapy in pancreatic cancer. Co-author DOI 10.1038/s41598-025-08431-2↗
  2. Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway. Co-author DOI 10.3892/or.2018.6202↗
  3. PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway. Co-author DOI 10.18632/oncotarget.21212↗
  4. Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer. Co-author DOI 10.1007/s13277-015-3233-5↗
  5. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0090476↗
  6. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.27715↗
  7. High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreat… First author DOI 10.1002/ijc.26290↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengguang Wang · 1 shared paper, 2025 · strength 0.26
  2. Daorong Wang · 5 shared papers, 2013–2018 · strength 0.24
  3. Dong Tang · 5 shared papers, 2012–2017 · strength 0.20
  4. Yi Miao · 4 shared papers, 2012–2015 · strength 0.14
  5. Kuirong Jiang · 4 shared papers, 2012–2015 · strength 0.14
  6. Ying Tian · 2 shared papers, 2017–2018 · strength 0.13
  7. Jun Gao · 2 shared papers, 2014–2015 · strength 0.08
  8. Dong Tang · 1 shared paper, 2018 · strength 0.07
  9. Zipeng Lu · 2 shared papers, 2012–2013 · strength 0.06
  10. Yong An · 2 shared papers, 2012–2013 · strength 0.06
  11. Xiaofeng Xue · 2 shared papers, 2012–2013 · strength 0.06
  12. Jishu Wei · 2 shared papers, 2012–2013 · strength 0.06
  13. Chuanqi Xu · 1 shared paper, 2015 · strength 0.04
  14. Jian‐Min Chen · 1 shared paper, 2013 · strength 0.03
  15. Min Tu · 1 shared paper, 2013 · strength 0.03
  16. Yi Zhu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.